loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for TT-00420

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    TT-00420

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    TransThera: Tinengotinib Solid Tumor Data
    TransThera: Tinengotinib Solid Tumor Data

    12 Apr 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/2024-aacr-late-breaking-researchtransthera-announces-clinical-data-of-tinengotinib-to-treat-patients-with-advanced-solid-tumors-harboring-actionable-fgfr1-3-alterations-302115397.html

    PR NEWSWIRE
    12 Apr 2024
    Share Share
    TransThera Announces Phase 3 Completed First Patient Dosing Evaluating Tinengotinib
    TransThera Announces Phase 3 Completed First Patient Dosing Evaluating Tinengotinib

    21 Dec 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/transthera-announces-the-global-multicenter-phase-3-clinical-trial-completed-first-patient-dosing-in-the-us-evaluating-tinengotinib-in-fgfri-relapsedrefractory-patients-with-cholangiocarcinoma-302021004.html

    PR NEWSWIRE
    21 Dec 2023
    Share Share
    TransThera announces an oral presentation of tinengotinib data in breast cancer
    TransThera announces an oral presentation of tinengotinib data in breast cancer

    07 Dec 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/2023-sabcs---transthera-announces-an-oral-presentation-of-tinengotinib-clinical-data-in-breast-cancer-302008583.html

    PR NEWSWIRE
    07 Dec 2023
    Share Share
    TransThera announces two oral presentations of tinengotinib clinical data
    TransThera announces two oral presentations of tinengotinib clinical data

    09 Oct 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/transthera-announces-two-oral-presentations-of-tinengotinib-clinical-data-at-2023-esmo-and-sabcs-annual-meetings-301950709.html

    PR NEWSWIRE
    09 Oct 2023
    Share Share